A topical composition for the treatment of inflammatory skin conditions including a butyrate active ingredient and a dermatologically acceptable carrier. The compositions include about 0.01 w/w % to about 20 w/w % butyrate, preferably a butyrate metal salt, and are free of a steroid. The compositions can be to the skin of a patient in need thereof in a method of treating inflammatory conditions of the skin.
